Zentek Ltd 6-K, filed Feb 15, 2023
Zentek Ltd. (ZTEKF)
About this 6-K
Zentek Ltd filed this 6-K on February 15, 2023.
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16
OF THE SECURITIES EXCHANGE ACT OF 1934
For the month of February 2023
Commission File Number: 001-41310
ZENTEK LTD.
(Registrant)
24 Corporate Court
Guelph, Ontario N1G 5G5 Canada
(Address of Principal Executive Offices)
Indicate by check mark whether the Registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Form 20-F ☐ Form 40-F ☒
Indicate by check mark if the Registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ☐
Indicate by check mark if the Registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ☐
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
|
|
ZENTEK LTD. |
|
|
|
(Registrant) |
|
|
|
|
|
|
Date: February 15, 2023 |
By |
/s/ Wendy Ford |
|
|
|
Wendy Ford |
|
|
|
Chief Financial Officer |
EXHIBIT INDEX
Zentek Introduces a Novel Corrosion Protection Technology: ZenARMOR™
Guelph, ON - February 8, 2023, Zentek Ltd. ("Zentek" or the "Company") (Nasdaq: ZTEK; TSX-V: ZEN), an intellectual property development and commercialization company, has developed ZenARMOR™, a novel corrosion protection technology based on functionalized Graphene Oxide (GO) that offers superior performance, self-healing properties and a potential environmental advantage. Corrosion is a costly issue that significantly impacts naval and marine infrastructure, bridges, buildings, pipelines, and many other industries. To help combat this problem, corrosion protective coatings can extend the life of existing infrastructure and equipment.
Highlights:
- Zentek has developed a novel corrosion protection technology with self-healing properties over the last 2 years;
- Third-party testing yielded excellent corrosion protection after 1,500 hours of ASTM B-117 Salt Spray Test with ZenARMOR™;
- Zentek has been pre-qualified for the Innovative Solutions Canada (ISC) Testing Stream - Military Call for Prototypes;
- Filed a Provisional Patent on this corrosion protection technology;
- Filed a Trademark for ZenARMOR™, the trade name for this novel technology;
- ZenARMOR™ potentially has an environmental advantage due to having very low loading of active ingredients compared to other corrosion protection products in the market.
"The economic cost of corrosion is significant. According to a United States Congressional Briefing on May 31, 2012, corrosion-related costs amounted to US$452 billion per year in the US, including US $22 billion for the Department of Defense. The global anti-corrosion coating market was estimated to be $27.4 Billion in 2019 and expected to grow to 63.7 Billion by 2030 according to Business Wire." said Greg Fenton, CEO of Zentek. "To help address this issue, corrosion protective coatings are used to extend the life of existing infrastructure and equipment, generally providing a high return on investment. With ZenARMOR™, our team has developed a nanomaterial-based technology that has the potential to further enhance this return on investment by not only improving the performance of existing corrosion protection solutions but doing so in a way that reduces environmental impact."
Third-Party Testing
The Company is collaborating with Quantum Chemical, a division of Quantum Technical Services Ltd., a manufacturer of high-performance primers and coatings. Testing by Quantum Chemical of ZenARMOR™ in an epoxy system following ASTM B-117 Salt Spray Testing demonstrated excellent corrosion resistance with no blisters or any other signs of corrosion after 1,500 hours with the addition of a very low dose of ZenARMOR™ versus the same corrosion protection epoxy without ZenARMOR™ which started breaking down at the 1000-hour mark. ZenARMOR™ is also comprised of fewer active ingredients compared to other products in the market, which management believes potentially has environmental benefits versus other corrosion protection products.
Testing is ongoing and the Company will report on further significant testing milestones.
Tony Lagrange, founder, and owner of Quantum Chemical since 1995 commented: These initial results of ZenARMOR™ after 1,500 hours of salt spray testing is impressive. Corrosion is a significant problem, and we are excited to be part of the Zentek testing and optimizing strategy for the ISC challenge and to help address this global corrosion problem. We are also leaders in the development of intumescent coating and paint products. We have significant in-house testing infrastructure equipment for intumescent coatings optimization. We are well positioned to work with Zentek on both corrosion and intumescent coating technologies that can improve performance and safety while reducing environmental impact."
Next Step: Innovative Solutions Canada Testing Stream - Military Call for Prototypes
The Company also reports that the ZenARMOR™ corrosion protection self-healing coating was submitted to the Innovative Solutions Canada (ISC) testing stream - Military Call for Prototypes. The Company is pleased to announce that it has been advised that ZenARMOR™ has met the mandatory and technical evaluation criteria of the Military Call for Prototypes, Military Component, and is considered conditionally qualified, pending further steps such as matching our innovation with a Government of Canada Organization (GCO) interested in testing ZenARMOR™. The Company and the ISC program have begun to socialize ZenARMOR™ to GCOs, exploring opportunities for partnership and testing. Conditionally qualified innovations are now listed on the ISC website.
Intellectual Property
The Company has filed a provisional patent with the United States Patent and Trademark Office for the ZenARMOR™ corrosion protection technology and has also filed a trademark for ZenARMOR™.
About Zentek Ltd.
Zentek is an IP development and commercialization company focused on the research, development and commercialization of novel products using graphene and nanomaterials for use in the healthcare industry and beyond.
Zentek's patented ZenGUARD™ coating is shown to have 99% antimicrobial activity and to significantly increase the bacterial and viral filtration efficiency of both surgical masks and HVAC systems. Zentek's ZenGUARD™ production facility is located in Guelph, Ontario.
For further information:
Mitch Swergold
Tel: (917) 930-8723
Email: mswergold@zentek.com
To find out more about Zentek Ltd., please visit our website at www.Zentek.com. A copy of this news release and all material documents in respect of the Company may be obtained on ZEN's SEDAR profile at http://www.sedar.com/.
Forward-Looking Statements
This news release contains forward-looking statements. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. Although Zentek believes that the assumptions and factors used in preparing the forward-looking information in this news release are reasonable, undue reliance should not be placed on such information, which only applies as of the date of this news release, and no assurance can be given that such events will occur in the disclosed time frames or at all. Zentek disclaims any intention or obligation to update or revise any forward-looking information, whether as a result of new information, future events or otherwise, other than as required by law.
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Zentek and 1329307 BC Ltd. Sign Letter of Intent to Spin Out
Albany Graphite Deposit
Guelph, ON - February 15, 2023, Zentek Ltd. ("Zentek") (Nasdaq: ZTEK; TSX-V: ZEN), an intellectual property development and commercialization company, and 1329307 BC Ltd. are pleased to announce that they have signed a non-binding letter of intent dated February 13, 2023 (the "LOI"), pursuant to which the parties have agreed to negotiate a transaction (the "Transaction") involving the transfer of Zentek's Albany Graphite Deposit in northern Ontario to an entity ("SpinCo") to be listed on a recognized Canadian stock exchange. The definitive structure of the Transaction will be determined following consultation with tax, securities and corporate advisors, provided that the parties currently intend that, following completion of the Transaction, Zentek shall retain a majority direct equity interest in SpinCo.
Zentek believes that transferring the Albany Graphite Deposit asset to a separate entity will enable the Albany Graphite project to move forward with the second year of environmental baseline and hydrogeology studies, with the aim to eventually complete a prefeasibility study. Management of Zentek believes that Zentek's current share price does not fully recognize the value of the Albany Graphite Deposit, and that, by completing the Transaction, Zentek, and accordingly its shareholders, will benefit from realizing the value of the asset.
"With significant production shortfalls anticipated in the next decade, and the limited number of producing mines and graphite deposits in geopolitically stable countries, the importance of North American graphite and our Albany Deposit is growing by the day," said Greg Fenton, CEO of Zentek. "Amidst this backdrop, we believe our strategy of using a separate entity to move Albany forward and pursuing funding directly for it gives us a compelling pathway to help unlock the value of our wholly-owned deposit for shareholders in the near and longer term."
The LOI was approved by the board of directors of each of Zentek and 1329307 BC Ltd. If and when a definitive binding agreement to consummate the Transaction is executed, Zentek and 1329307 BC Ltd. will issue a subsequent news release containing the details of the definitive agreement and other matters of material significance. While each of Zentek and 1329307 BC Ltd. currently expects to complete the Transaction, the completion of the Transaction will be subject to several conditions, including but not limited to, receiving all required shareholder, regulatory, stock exchange and other corporate and third-party approvals. As such, there can be no assurance that the Transaction will be completed as proposed, or at all.
Albany Graphite Deposit
Zentek currently owns 100% of the Albany Graphite Deposit. The determination by Zentek to proceed with the transfer of the Albany Graphite Deposit to SpinCo follows the expiration of the agreement with The Benchmark Company, originally announced on April 18, 2022. Benchmark was retained to explore strategic alternatives to unlock the value of the Albany Graphite Deposit. Given the acute focus on the development of domestic, critical mineral supply chains, it was determined that transferring the Albany Graphite Deposit from Zentek to a separate entity as described above was the optimal path. A separate entity holding the asset will allow the value of the Albany Graphite Deposit to be defined, and will provide a vehicle to advance the project, independent of Zentek's core intellectual property development business.
About Zentek
Zentek is an IP development and commercialization company focused on the research, development and commercialization of novel products using graphene and nanomaterials for use in the healthcare industry and beyond.
Zentek's patented ZenGUARD™ coating is shown to have 99% antimicrobial activity and to significantly increase the bacterial and viral filtration efficiency of both surgical masks and HVAC systems. Zentek's ZenGUARD™ production facility is in Guelph, Ontario.
For further information:
Zentek
Mitch Swergold, Director of Investor Relations
Tel: (917) 930-8723
Email: mswergold@zentek.com
Dr. Francis Dubé, Executive Chairman
Tel: (289) 821-2820
Email: fdube@zentek.com
To find out more about Zentek Ltd., please visit our website at www.Zentek.com. A copy of this news release and all material documents in respect of the Company may be obtained on ZEN's SEDAR profile at http://www.sedar.com/.
1329307 BC Ltd.
Arvin Ramos
Chief Financial Officer
Tel: (416) 361-2829
Forward-Looking Statements
This news release contains forward-looking statements. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. Although each of Zentek and 1329307 BC Ltd. believes that the assumptions and factors used in preparing the forward-looking information in this news release are reasonable, undue reliance should not be placed on such information, which only applies as of the date of this news release, and no assurance can be given that such events will occur in the disclosed time frames or at all. Each of Zentek and 1329307 BC Ltd. disclaims any intention or obligation to update or revise any forward-looking information, whether as a result of new information, future events or otherwise, other than as required by law.
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.